definitive radiation

Radiation oncology Administration of radiation as a sole or 1º therapy, usually for CA, with curative intent; DR doses average 40-50 Gy/4-5000 rads. See Radiation therapy.

Mentioned in ?

References in periodicals archive ?

Garg et al., "ACR appropriateness criteria[R] retreatment of recurrent head and neck cancer after prior definitive radiation: Expert panel on radiation oncology-head and neck cancer," International Journal of Radiation Oncology * Biology * Physics, vol.

Evaluation of Reirradiation in Locally Advanced Head and Neck Cancers: Toxicity and Early Clinical Outcomes

Shedden et al., "Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy," International Journal of Radiation Oncology Biology Physics, vol.

Exhaled Nitric Oxide Is Useful in Symptomatic Radioactive Pneumonia: A Retrospective Study

Pneumocephalus after radiation alone is rare and has been described in cases of definitive radiation for treatment of nasopharyngeal carcinoma.

Pneumocephalus after the Treatment of an Inoperable Superior Sulcus Tumor with Chemoradiation

Definitive radiation therapy for early glottic cancer: experience of two fractionation schedules.

Therapeutic effects of sequential chemoradiotherapy with pemetrexed and cisplatin on locally advanced laryngeal cancer

Protection against nuclear or radiological attack has motivated the search for more definitive radiation detection and identification technologies.

Radiation detection: Lawrence Livermore National Laboratory

A prospective clinical study provides a direct comparison between cisplatin and paclitaxel used as weekly concurrent chemotherapy with definitive radiation for locally advanced carcinoma cervix.

A comparative evaluation of radiotherapy with concurrent weekly cisplatin versus concurrent weekly paclitaxel in patients with locally advanced carcinoma cervix

Definitive radiation treatment with chemotherapy is utilized as the initial treatment strategy for many advanced laryngeal cancers except those with cartilage involvement.

Predictors of salivary fistulas in patients undergoing salvage total laryngectomy

Management of prostate cancer recurrence after definitive radiation therapy.

Salvage prostatectomy post-definitive radiation therapy: The Vancouver experience

Ki-67 cut-off levels of <3.5% and >7.1% were used based on retrospective validation of these values in predicting outcomes following definitive radiation treatment in patients treated on two separate RTOG trials [15, 16].

Quantifying the Ki-67 heterogeneity profile in prostate cancer

Value of computed tomography as outcome predictor of supraglottic squamous cell carcinoma treated by definitive radiation therapy.

Association between tumour volume and recurrence of squamous cell carcinoma of the head and neck

These include adjuvant therapy for resected squamous cell carcinoma of the head and neck (new); local-regional therapy for resectable oropharyngeal squamous cell carcinomas; and retreatment of recurrent head and neck cancer after prior definitive radiation.

Guidelines for imaging of head and neck cancers

"This study, along with other emerging studies, strongly suggests that statin use improves outcomes in patients treated with definitive radiation therapy," added Zelefsky.